Literature DB >> 29226158

Corrigendum to "The Controversial C5a Receptor C5aR2: Its Role in Health and Disease".

Ting Zhang1, Malgorzata A Garstka1, Ke Li1.   

Abstract

[This corrects the article DOI: 10.1155/2017/8193932.].

Entities:  

Year:  2017        PMID: 29226158      PMCID: PMC5687145          DOI: 10.1155/2017/6073961

Source DB:  PubMed          Journal:  J Immunol Res        ISSN: 2314-7156            Impact factor:   4.818


In the article titled “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease” [1], there was an error in Table 4, where Jun/fos-A8△71–73 should be corrected to A8△71–73. The corrected table is as follows:
Table 4

C5aR2 agonists and antagonists.

LigandSpecificityFunctionRefs
Jun/fos-A8A8△71–73C5 mutant peptidesHuman and murine C5aR1 and C5aR2Antagonists—block binding of C5a and C5ades Arg to C5aRs[51]
P32, P59—C terminal peptides of C5ahC5aR2Agonists—strongly stimulate the association of hC5aR2 with β-arrestin 2[21, 127]
LukS-PV—protein from S. aureusHuman and rabbit C5aR1Human, macaque, and rabbit C5aR2Antagonist of C5a-induced activation of neutrophils[48, 128]
HIgCB—protein complex from S. aureusHuman, macaque, rabbit, and cow C5aRsAntagonist of C5a-induced activation of neutrophils[128, 129]
  1 in total

Review 1.  The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.

Authors:  Ting Zhang; Malgorzata A Garstka; Ke Li
Journal:  J Immunol Res       Date:  2017-06-15       Impact factor: 4.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.